Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Lung Cancer

Free Subscription Articles published in Ann Oncol Retrieve available abstracts of 74 articles: HTML format

Single Articles

June 2008
1. HAYES DN , McLeod HL
   EGFR regulation by microRNA in lung cancer: a rose by any other name ... is an increasingly complicated rose.
   Ann Oncol. 2008;19:1036-7.
   PubMed     Related articles   
   
   
   May 2008
2. SCULIER JP , Lafitte JJ, Efremidis A, Florin MC, et al
   A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer.
   Ann Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. ZUCALI PA , Ruiz MG, Giovannetti E, Destro A, et al
   Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.
   Ann Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. SORENSEN M , Felip E
   Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
   Ann Oncol. 2008;19 Suppl 2:ii41-2.
   PubMed     Related articles   
   
   
   
5. D'ADDARIO G , Felip E
   Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
   Ann Oncol. 2008;19 Suppl 2:ii39-40.
   PubMed     Related articles   
   
   
   
6. GREYSTOKE A , Cummings J, Ward T, Simpson K, et al
   Optimisation of circulating biomarkers of cell death for routine clinical use.
   Ann Oncol. 2008;19:990-5.
   PubMed     Related articles    Abstract available
   
   
   
7. LABIANCA R , Garassino M, Torri V
   Predicting response of molecular targeted therapies: a still possible challenge?
   Ann Oncol. 2008;19:829-30.
   PubMed     Related articles   
   
   
   
8. BATTY GD , Kivimaki M, Gray L, Smith GD, et al
   Cigarette smoking and site-specific cancer mortality: testing uncertain associations using extended follow-up of the original Whitehall study.
   Ann Oncol. 2008;19:996-1002.
   PubMed     Related articles    Abstract available
   
   
   April 2008
9. GIACCONE G , Zucali PA
   Src as a potential therapeutic target in non-small-cell lung cancer.
   Ann Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. PAPAXOINIS G , Fountzilas G, Rontogianni D, Dimopoulos MA, et al
    Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG).
    Ann Oncol. 2008;19:780-6.
    PubMed     Related articles    Abstract available
    
    
    
11. FULCINITI F , Losito S, Botti G, Di Mattia D, et al
    Metastases to the breast: role of fine needle cytology samples. Our experience with nine cases in 2 years.
    Ann Oncol. 2008;19:682-7.
    PubMed     Related articles    Abstract available
    
    
    March 2008
12. JACOT W , Colinet B, Bertrand D, Lacombe S, et al
    Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients.
    Ann Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. MACHIELS JP , Bletard N, Pirenne P, Jacquet L, et al
    Acute cardiac failure after sunitinib.
    Ann Oncol. 2008;19:597-9.
    PubMed     Related articles   
    
    
    
14. POWLES T , Robinson D, Shamash J, Moller H, et al
    The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis.
    Ann Oncol. 2008;19:443-7.
    PubMed     Related articles    Abstract available
    
    
    
15. KU GY , Minsky BD, Rusch VW, Bains M, et al
    Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience.
    Ann Oncol. 2008;19:533-7.
    PubMed     Related articles    Abstract available
    
    
    
16. AAPRO M , Abrahamsson PA, Body JJ, Coleman RE, et al
    Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel.
    Ann Oncol. 2008;19:420-32.
    PubMed     Related articles    Abstract available
    
    
    February 2008
17. WEISS GJ , Bemis LT, Nakajima E, Sugita M, et al
    EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines.
    Ann Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. CULLEN MH , Zatloukal P, Sorenson S, Novello S, et al
    A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer.
    Ann Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
19. DI MAIO M , Bria E, Rossi A, Perrone F, et al
    Progression-free survival as primary end point in advanced non-small-cell lung cancer: does the size matter?
    Ann Oncol. 2008;.
    PubMed     Related articles   
    
    
    December 2007
20. D'ADDARIO G , Rauch D, Stupp R, Pless M, et al
    Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
21. WITZEL ID , Muller V, Harps E, Janicke F, et al
    Trastuzumab in pregnancy associated with poor fetal outcome.
    Ann Oncol. 2007;.
    PubMed     Related articles   
    
    
    October 2007
22. LEE JM , Lee KB, Nam JH, Ryu SY, et al
    Prognostic factors in FIGO stage IB IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
23. ROSELL R , Robinet G, Szczesna A, Ramlau R, et al
    Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
24. KOSMIDIS PA , Kalofonos HP, Christodoulou C, Syrigos K, et al
    Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    September 2007
25. RUANO-RAVINA A , Perez-Becerra R, Fraga M, Kelsey KT, et al
    Analysis of the relationship between p53 immunohistochemical expression and risk factors for lung cancer, with special emphasis on residential radon exposure.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. LEE D , Kim SW, Suh C, Lee JS, et al
    Belotecan, new camptothecin analogue, is active in patients with small-cell lung cancer: results of a multicenter early phase II study.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
27. KIM DW , Kim SY, Kim HK, Kim SW, et al
    Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
28. SCAGLIOTTI GV
    Potential role of multi-targeted tyrosine kinase inhibitors in non-small-cell lung cancer.
    Ann Oncol. 2007;18 Suppl 10:x32-41.
    PubMed     Related articles    Abstract available
    
    
    August 2007
29. PAUTIER P , Ribrag V, Duvillard P, Rey A, et al
    Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
30. TOSCHI L , Cappuzzo F, Janne PA
    Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancer.
    Ann Oncol. 2007;18 Suppl 9:ix150-5.
    PubMed     Related articles   
    
    
    
31. FELIP E , Cedres S, Peralta S, Prat A, et al
    Adjuvant chemotherapy in non-small cell lung cancer (NSCLC).
    Ann Oncol. 2007;18 Suppl 9:ix143-6.
    PubMed     Related articles   
    
    
    
32. BESSE B , Ropert S, Soria JC
    Targeted therapies in lung cancer.
    Ann Oncol. 2007;18 Suppl 9:ix135-42.
    PubMed     Related articles   
    
    
    
33. STAHEL RA
    Adenocarcinoma, a molecular perspective.
    Ann Oncol. 2007;18 Suppl 9:ix147-9.
    PubMed     Related articles   
    
    
    
34. LARKIN JM , Kaye SB
    Potential clinical applications of epothilones: a review of phase II studies.
    Ann Oncol. 2007;18 Suppl 5:v28-34.
    PubMed     Related articles    Abstract available
    
    
    
35. MEDIONI J , Cojocarasu O, Belcaceres JL, Halimi P, et al
    Complete cerebral response with sunitinib for metastatic renal cell carcinoma.
    Ann Oncol. 2007;18:1282-3.
    PubMed     Related articles   
    
    
    
36. VINEIS P , Veglia F, Garte S, Malaveille C, et al
    Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers.
    Ann Oncol. 2007;18:1230-42.
    PubMed     Related articles    Abstract available
    
    
    June 2007
37. YU I , Tse L, Leung C, Wong T, et al
    Lung cancer mortality among silicotic workers in Hong Kong--no evidence for a link.
    Ann Oncol. 2007;18:1056-1063.
    PubMed     Related articles    Abstract available
    
    
    
38. LAURIE S , Ding K, Whitehead M, Feld R, et al
    The impact of anemia on outcome of chemoradiation for limited small-cell lung cancer: a combined analysis of studies of the National Cancer Institute of Canada Clinical Trials Group.
    Ann Oncol. 2007;18:1051-5.
    PubMed     Related articles    Abstract available
    
    
    
39. ROSATI G , Bilancia D, Germano D, Dinota A, et al
    Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer: a phase II study.
    Ann Oncol. 2007;18 Suppl 6:vi128-32.
    PubMed     Related articles    Abstract available
    
    
    
40. DIRIX LY , Maes H, Sweldens C
    Treatment of arterial hypertension (AHT) associated with angiogenesis inhibitors.
    Ann Oncol. 2007;18:1121-2.
    PubMed     Related articles   
    
    
    
41. BOFFETTA P
    Epidemiology of peritoneal mesothelioma: a review.
    Ann Oncol. 2007;18:985-90.
    PubMed     Related articles    Abstract available
    
    
    May 2007
42. 
    Small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up.
    Ann Oncol. 2007;18 Suppl 2:ii32-ii33.
    PubMed     Related articles       Free Full Text
    
    
    
43. 
    Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up.
    Ann Oncol. 2007;18 Suppl 2:ii30-ii31.
    PubMed     Related articles       Free Full Text
    
    
    
44. DAGNELIE PC , Pijls-Johannesma MC, Lambin P, Beijer S, et al
    Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy.
    Ann Oncol. 2007;18:940-4.
    PubMed     Related articles    Abstract available
    
    
    April 2007
45. SCULIER J , Lafitte J, Lecomte J, Alexopoulos C, et al
    A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. ALTINTAS S , Blockx N, Huizing MT, Van den Brande J, et al
    Small-cell carcinoma of the penile urethra: a case report and a short review of the literature.
    Ann Oncol. 2007;18:801-4.
    PubMed     Related articles   
    
    
    March 2007
47. TAILLADE L , Penault-Llorca F, Boulet T, Fouret P, et al
    Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
48. NOVELLO S , Bruzzi P, Barone C, Buosi R, et al
    Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
49. WEISS G , Rosell R, Fossella F, Perry M, et al
    The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer.
    Ann Oncol. 2007;18:453-60.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
50. VAN ZANDWIJK N , van de Vijver MJ
    Clairvoyance or reliable prediction of the future?
    Ann Oncol. 2007;18:407-8.
    PubMed     Related articles   
    
    
    
51. VIEILLOT S , Pouessel D, de Champfleur NM, Becht C, et al
    Reversible posterior leukoencephalopathy syndrome after carboplatin therapy.
    Ann Oncol. 2007;18:608-9.
    PubMed     Related articles   
    
    
    
52. LEVI F , Lucchini F, Negri E, La Vecchia C, et al
    Continuing declines in cancer mortality in the European Union.
    Ann Oncol. 2007;18:593-5.
    PubMed     Related articles    Abstract available
    
    
    February 2007
53. DE RUYSSCHER D , Dehing C, Bremer RH, Bentzen S, et al
    Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
54. HIRSCH F , Varella-Garcia M, Cappuzzo F, McCoy J, et al
    Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
55. MANDALA M , Moro C, Michetti G, Ferretti G, et al
    What is the real benefit of adjuvant chemotherapy in the Adjuvant Navelbine International Trialist Association trial?
    Ann Oncol. 2007;18:404.
    PubMed     Related articles   
    
    
    December 2006
56. YOON S , Schmassmann-Suhijar D, Zuber M, Konietzny P, et al
    Chemotherapy with bevacizumab, irinotecan, 5-fluorouracil and leucovorin (IFL) associated with a large, embolizing thrombus in the thoracic aorta.
    Ann Oncol. 2006;17:1851-2.
    PubMed     Related articles   
    
    
    November 2006
57. BIDOLI P , Zilembo N, Cortinovis D, Mariani L, et al
    Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
58. DZIADZIUSZKO R , Holm B, Skov BG, Osterlind K, et al
    Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
59. OHE Y , Ohashi Y, Kubota K, Tamura T, et al
    Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
60. SOUGLAKOS J , Kalykaki A, Vamvakas L, Androulakis N, et al
    Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    October 2006
61. SEIFART U , Fink T, Schade-Brittinger C, Hans K, et al
    Randomised phase II study comparing topotecan/carboplatin administration for 5 versus 3 days in the treatment of extensive-stage small-cell lung cancer.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
62. COMELLA P , Filippelli G, De Cataldis G, Massidda B, et al
    Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperativ
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
63. ROCHA-LIMA CM , Herndon JE 2nd, Lee ME, Atkins JN, et al
    Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
64. GALEONE C , Negri E, Pelucchi C, La Vecchia C, et al
    Dietary intake of fruit and vegetable and lung cancer risk: a case-control study in Harbin, northeast China.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
65. FISCHER BM , Mortensen J, Langer SW, Loft A, et al
    A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
66. VAN ZANDWIJK N , Mathy A, Boerrigter L, Ruijter H, et al
    EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
67. BELANI CP , Dakhil S, Waterhouse DM, Desch CE, et al
    Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
68. ANDRE T , Tournigand C, Mineur L, Fellague-Chebra R, et al
    Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study.
    Ann Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    September 2006
69. STAHEL RA
    Non-small cell lung cancer: second-line and beyond.
    Ann Oncol. 2006;17 Suppl 10:x97-x100.
    PubMed     Related articles   
    
    
    
70. FELIP E , Vilar E
    The expanding role of systemic treatment in non-small cell lung cancer neo-adjuvant therapy.
    Ann Oncol. 2006;17 Suppl 10:x108-x112.
    PubMed     Related articles   
    
    
    
71. LORIOT Y , Soria JC, Le Chevalier T
    Expanding role of chemotherapy in lung cancer.
    Ann Oncol. 2006;17 Suppl 10:x101-x107.
    PubMed     Related articles   
    
    
    August 2006
72. ZELL JA , Ou SH, Ziogas A, Anton-Culver H, et al
    Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis.
    Ann Oncol. 2006;17:1255-62.
    PubMed     Related articles    Abstract available
    
    
    June 2006
73. ITALIANO A , Vandenbos FB, Otto J, Mouroux J, et al
    Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitors.
    Ann Oncol. 2006;17:981-5.
    PubMed     Related articles    Abstract available
    
    
    May 2006
74. CRIVELLARI D , Lombardi D, Corona G, Massacesi C, et al
    Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring.
    Ann Oncol. 2006;17:807-12.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: